ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,066.19
      -0.98%
      US Tech 100
      17,092.20
      -1.26%
      Dow Jones
      37,967.93
      -1.09%
      Brent Oil
      86.125
      -1.33%
      Bitcoin
      60,175.66
      -5.74%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aptorum Group Ltd (APM)

      7. Aptorum Group Ltd (APM) News

      APM

      Aptorum (APM)

      Aptorum Group Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:APM
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      04/30/20249:15AMBusiness WireAptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
      03/06/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      03/06/20248:00AMBusiness WireAptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy BusinessNASDAQ:APMAptorum Group Ltd
      12/22/20234:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      12/22/20234:30PMBusiness WireAptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023NASDAQ:APMAptorum Group Ltd
      12/21/20234:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      12/21/20234:30PMBusiness WireAptorum Group Limited Announces Results of 2023 Annual General Meeting of ShareholdersNASDAQ:APMAptorum Group Ltd
      11/30/20234:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      11/21/202310:25AMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
      11/16/202311:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      11/16/202311:00AMBusiness WireAptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023NASDAQ:APMAptorum Group Ltd
      09/11/20234:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      08/10/20236:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      08/10/20232:57AMBusiness WireAptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital MarketsNASDAQ:APMAptorum Group Ltd
      07/14/20234:30PMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
      06/30/20234:31PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      06/30/20234:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
      06/22/20238:00AMBusiness WireAptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for NeuroblastomaNASDAQ:APMAptorum Group Ltd
      06/09/20234:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
      06/09/20234:30PMBusiness WireAptorum Group Limited Announces Voluntary Delisting from Euronext ParisNASDAQ:APMAptorum Group Ltd
      05/24/20239:01AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APMAptorum Group Ltd
      05/22/20236:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APMAptorum Group Ltd
      05/17/20234:31PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:APMAptorum Group Ltd
      05/08/20239:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
      05/05/20234:31PMBusiness WireAptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity DeficiencyNASDAQ:APMAptorum Group Ltd
      05/03/20239:29AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APMAptorum Group Ltd
      05/01/20238:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
      05/01/20238:00AMBusiness WireAptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations LimitedNASDAQ:APMAptorum Group Ltd
      04/28/20239:44AMBusiness WireAptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
       Showing the most relevant articles for your search:NASDAQ:APM